Literature DB >> 26560149

Survival in Resected Stage II Colorectal Cancer Is Dependent on Tumor Depth, Vascular Invasion, Postoperative CEA Level, and The Number of Examined Lymph Nodes.

Hsiang-Lin Tsai1,2,3, Ching-Wen Huang1,2,4, Chao-Wen Chen3,5, Yung-Sung Yeh1,4, Cheng-Jen Ma1,4,6, Jaw-Yuan Wang7,8,9,10,11,12.   

Abstract

BACKGROUND: The aim of the present study was to determine which aspects of tumor histology influence postoperative early relapse and overall survival rates after radical resection of stage II colorectal cancer (CRC).
METHODS: Data were collected for 425 patients with stage II CRC who began treatment at a single institution between January 2006 and October 2013. All the enrolled patients were followed up on until death or until December 2014. Clinically significant factors affecting postoperative early relapse and overall survival rates were analyzed.
RESULTS: Using a multivariate analysis, tumor invasion depth (P = 0.008), vascular invasion (P = 0.029), postoperative carcinoembryonic antigen (CEA) level (P = 0.001), and retrieval of less than 12 lymph nodes (P = 0.002) were found to be independent predictors for postoperative early relapse. A combination of tumor invasion depth, vascular invasion, postoperative CEA level, and number of lymph nodes retrieved showed that the greater the number of predictors involved, the higher the likelihood of postoperative early relapse and the poorer the overall survival.
CONCLUSIONS: This study revealed that T4 invasion, vascular invasion, postoperative CEA level, and the number of examined lymph nodes may significantly affect the prognosis of stage II CRC patients after radical resection. The risks of postoperative early relapse and worse clinical outcome increase in proportion to the values of these four parameters.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26560149     DOI: 10.1007/s00268-015-3331-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Prognostic factors in node-negative colorectal cancer: a retrospective study from a prospective database.

Authors:  Gregoire Desolneux; Pascal Burtin; Emilie Lermite; Roberto Bergamaschi; Antoine Hamy; Jean Pierre Arnaud
Journal:  Int J Colorectal Dis       Date:  2010-04-20       Impact factor: 2.571

2.  Population-based study of prognostic factors in stage II colonic cancer.

Authors:  M Morris; C Platell; B de Boer; K McCaul; B Iacopetta
Journal:  Br J Surg       Date:  2006-07       Impact factor: 6.939

3.  S100B protein expressions as an independent predictor of early relapse in UICC stages II and III colon cancer patients after curative resection.

Authors:  Chi-Ching Hwang; Han-Tan Chai; Hsin-Wei Chen; Hsiang-Lin Tsai; Chien-Yu Lu; Fang-Jung Yu; Ming-Yii Huang; Jaw-Yuan Wang
Journal:  Ann Surg Oncol       Date:  2010-07-14       Impact factor: 5.344

4.  Absence of extramural venous invasion is an excellent predictor of metastasis-free survival in colorectal carcinoma stage II--a study using tangential tissue sectioning.

Authors:  Klaus Dirschmid; William Sterlacci; Frank Oellig; Michael Edlinger; Zerina Jasarevic; Michaela Rhomberg; Harald Dirschmid; Felix Offner
Journal:  J Clin Pathol       Date:  2012-05-03       Impact factor: 3.411

Review 5.  Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma.

Authors:  S Ambiru; M Miyazaki; H Ito; K Nakagawa; H Shimizu; A Kato; S Nakamura; H Omoto; N Nakajima
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

6.  Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.

Authors:  Yoon-Ah Park; Kang Young Lee; Nam Kyu Kim; Seung Hyuk Baik; Seung Kook Sohn; Chang Whan Cho
Journal:  Ann Surg Oncol       Date:  2006-03-13       Impact factor: 5.344

7.  Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.

Authors:  J Y Wang; C Y Lu; K S Chu; C J Ma; D C Wu; H L Tsai; F J Yu; J S Hsieh
Journal:  Eur Surg Res       Date:  2007-04-23       Impact factor: 1.745

8.  Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

Authors:  Michael J O'Connell; Megan E Campbell; Richard M Goldberg; Axel Grothey; Jean-François Seitz; Jacqueline K Benedetti; Thierry André; Daniel G Haller; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2008-05-10       Impact factor: 44.544

9.  Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.

Authors:  Ryash Vather; Tarik Sammour; Arman Kahokehr; Andrew B Connolly; Andrew G Hill
Journal:  Ann Surg Oncol       Date:  2008-12-31       Impact factor: 5.344

10.  The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.

Authors:  J L McCall; R B Black; C A Rich; J R Harvey; R A Baker; J M Watts; J Toouli
Journal:  Dis Colon Rectum       Date:  1994-09       Impact factor: 4.585

View more
  14 in total

1.  Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer.

Authors:  Xianzhe Li; Zhizhong Xiong; Minghao Xie; Qunsheng Huang; Longyang Jin; Shi Yin; Shuanggang Chen; Ping Lan; Lei Lian
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  Identification of Genomic Alterations of Perineural Invasion in Patients with Stage II Colorectal Cancer.

Authors:  Hao Su; Chen Chang; Jiajie Hao; Xin Xu; Mandula Bao; Shou Luo; Chuanduo Zhao; Qian Liu; Xishan Wang; Zhixiang Zhou; Haitao Zhou
Journal:  Onco Targets Ther       Date:  2020-11-11       Impact factor: 4.147

3.  Stage migration resulting from inadequate number of examined lymph nodes impacts prognosis in stage II colon cancer after radical surgery.

Authors:  Di Xie; Xiangping Song; Lingling Tong
Journal:  Int J Colorectal Dis       Date:  2020-11-10       Impact factor: 2.571

4.  A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.

Authors:  Yuan Zeng; Nicholas Mayne; Chi-Fu Jeffrey Yang; Jun Liu; Fei Cui; Jingpei Li; Wenhua Liang; Jianxing He
Journal:  Transl Lung Cancer Res       Date:  2021-04

5.  Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer.

Authors:  Han-Gil Kim; Seung Yoon Yang; Yoon Dae Han; Min Soo Cho; Byung Soh Min; Kang Young Lee; Nam Kyu Kim; Hyuk Hur
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

6.  Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.

Authors:  Li-Guo Liu; Xue-Bing Yan; Ru-Ting Xie; Zhi-Ming Jin; Yi Yang
Journal:  Med Sci Monit       Date:  2017-06-14

7.  The impacts of surgery of the primary cancer and radiotherapy on the survival of patients with metastatic rectal cancer.

Authors:  Duo Tong; Fei Liu; Wenhua Li; Wen Zhang
Journal:  Oncotarget       Date:  2017-07-11

8.  Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.

Authors:  Tsuyoshi Konishi; Yoshifumi Shimada; Meier Hsu; Lauren Tufts; Rosa Jimenez-Rodriguez; Andrea Cercek; Rona Yaeger; Leonard Saltz; J Joshua Smith; Garrett M Nash; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Mithat Gonen; Martin R Weiser
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777

9.  Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.

Authors:  I-Ping Yang; Hsiang-Lin Tsai; Zhi-Feng Miao; Ching-Wen Huang; Chao-Hung Kuo; Jeng-Yih Wu; Wen-Ming Wang; Suh-Hang Hank Juo; Jaw-Yuan Wang
Journal:  J Transl Med       Date:  2016-04-29       Impact factor: 5.531

10.  The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels.

Authors:  Hai-Lun Xie; Yi-Zhen Gong; Jia-An Kuang; Feng Gao; Shuang-Yi Tang; Jia-Liang Gan
Journal:  Cancer Manag Res       Date:  2019-08-07       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.